PAREXEL Introduces New Dedicated Division to Help Emerging Biotech Companies Reach their Goals

Published on: 

Applied Clinical Trials

PAREXEL International Corporation, an innovator of global biopharmaceutical services, introduced a new, dedicated division to help emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively. PAREXEL utilizes different strategies and services such as consulting, patient recruitment, trial execution, and Real World Evidence programs in order to help companies reach their objectives.

Read the full release here.